. . . . . . . . . . . . . . "a(CHEBI:wortmannin) -| kin(p(HGNC:MAPK1))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "Immunoblotting (western blotting) of whole NK92 cell lysates after target engagement demonstrated that both LY294002 and wortmannin treatment significantly inhibited ERK1/2 and MEK1 and MEK2 (MEK1/2) phosphorylation in a dose dependent manner (Fig. 2a,b)." . . "Selventa" . . . . "2014-07-03T14:31:37.909+02:00"^^ . . .